Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...

Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...

New legislation proposed by a bipartisan and bicameral group of Congressional legislators and supported by the North Carolina ...

Join AgBio+AgTech at the First Flight Venture Center for a conversation with Dr. Sharon Inch, plant pathologist and innovator behind Soil Sync and AgVision Analytics. Dr. Inch will share how she ...

Join Innovate Carolina on December 4 for an evening celebrating innovation, invention, and the journey from academic discovery to real-world impact.

Innatrix‘s lead product, InnaNema, targets soybean cyst nematode, one of the most damaging pests for U.S. soybean crops.

URO-1, a Greensboro medical device company in prostate and soft tissue cancer diagnostics, said it was recently approved by Novant Health as a designated vendor for URO-1’s SUREcore and coreCARE ...

Six months after launching research-grade human collagen, Phoenix-based Humabiologics announced its first expansion, to Winston-Salem’s Innovation Quarter, on Nov. 12. The company will use the ...

Novartis Gene Therapies, a division of Switzerland-based Novartis, one of the world’s largest pharmaceutical companies, plans to expand in the Research Triangle with $771 million of investments at ...

Tract Bio, a Boston-based biotechnology company developing novel therapies for cancer and inflammatory diseases, has opened a new research laboratory in Charlotte with plans to grow. The 4,000 ...